Capital World Investors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-250,000
Closed -$28M 529
2019
Q4
$28M Sell
250,000
-350,000
-58% -$37.3M 0.01% 397
2019
Q3
$57.7M Hold
600,000
0.01% 331
2019
Q2
$51.3M Hold
600,000
0.01% 344
2019
Q1
$49.9M Hold
600,000
0.01% 349
2018
Q4
$38.5M Hold
600,000
0.01% 369
2018
Q3
$47.5M Hold
600,000
0.01% 383
2018
Q2
$43.9M Sell
600,000
-43,000
-7% -$2.92M 0.01% 377
2018
Q1
$40.7M Hold
643,000
0.01% 369
2017
Q4
$32.8M Sell
643,000
-465,000
-42% -$24.2M 0.01% 387
2017
Q3
$58.1M Hold
1,108,000
0.01% 343
2017
Q2
$56.4M Hold
1,108,000
0.01% 336
2017
Q1
$49.2M Hold
1,108,000
0.01% 353
2016
Q4
$48.9M Hold
1,108,000
0.01% 347
2016
Q3
$44.4M Hold
1,108,000
0.01% 347
2016
Q2
$52.9M Hold
1,108,000
0.01% 325
2016
Q1
$46.5M Hold
1,108,000
0.01% 339
2015
Q4
$48.8M Hold
1,108,000
0.01% 348
2015
Q3
$52.9M Buy
1,108,000
+133,000
+14% +$7.3M 0.02% 344
2015
Q2
$56.8M Buy
975,000
+50,000
+5% +$2.7M 0.02% 354
2015
Q1
$46.7M Buy
+925,000
New +$45.3M 0.01% 374

Other funds holding CNMD

Capital World Investors's CNMD Position: Q1 2020 in Review

Capital World Investors sold out of CONMED (CNMD) in Q1 2020, closing a stake of 250,000 shares — an estimated $28M sold.

Capital World Investors first reported a position in CNMD in Q1 2015 and held it in 20 quarters. The position peaked at $58.1M in Q3 2017. 229 funds tracked by Wall St. Rank hold CNMD as of Q1 2020.

  • Capital World Investors reported no remaining CONMED position as of Q1 2020 after selling out during the quarter.
  • Capital World Investors sold 250,000 CONMED shares in Q1 2020, an estimated $28M.
  • Capital World Investors first reported a position in CONMED in Q1 2015 and held it in 20 quarters.
  • Capital World Investors's CONMED position peaked at $58.1M in Q3 2017.
  • 229 funds tracked by Wall St. Rank held CONMED as of Q1 2020.

Based on Capital World Investors's 13F filing for Q1 2020, filed 15 May 2020.